PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
An aqueous extract of C. texana possesses antigenotoxic and antimutagenic properties and is not mutagenic or genotoxic in prokaryotic and eukaryotic systems [PMID:15582360].
Methanolic extracts of C. texana were screened for trypanocidal activity, though it was not among the species exhibiting the highest growth inhibition [PMID:24742906].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 15582360 (2005) — The amoebicidal aqueous extract from Castela texana possesses antigenotoxic and antimutagenic properties. · Toxicology in vitro : an international journal published in association with BIBRA
- 2.PMID: 8984156 (1996) — A new quassinoid from Castela texana. · Journal of natural products
- 3.PMID: 24742906 (2014) — Anti-Trypanosoma cruzi activity of 10 medicinal plants used in northeast Mexico. · Acta tropica